Top Markets
#1 Islamic Coin Islamic Coin +154.50%
#2 PulseChain PulseChain +49.22%
#3 RedStone RedStone +23.91%
#4 MarsCoin MarsCoin +12.77%
#5 Nockchain Nockchain +12.59%
#6 BOOK OF MEME BOOK OF MEME +11.85%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.84%
#8 SkyAI SkyAI +8.96%
#9 Lighter Lighter +8.81%
#10 Monad Monad +8.69%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MedMira Inc. MedMira Inc.

MedMira Inc.

MIR
Kedudukan dalam Saham #27733
MedMira Inc. is a biotechnology company focused on the research, development,... MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia Pacific region, and other international markets. MedMira offers a diverse portfolio of rapid diagnostic tests and technology platforms. Its diagnostic solutions include Reveal HIV, which identifies HIV-1 and HIV-2 antibodies in various blood samples; Reveal TP, a rapid test for syphilis antibodies (Treponema pallidum); and Reveal HP, designed to detect Helicobacter pylori antibodies. The company also provides Multiplo, a line of multiplex tests for combined screening of conditions such as HIV-1/2, Hepatitis B and C, and syphilis, as well as the Miriad triple product for initial HIV and hepatitis screening. In the realm of respiratory and viral diagnostics, MedMira developed VYRA CoV2 for SARS-CoV-2 nucleocapsid antigen detection, VYRA CoV2Flu for simultaneous antigen testing of SARS-CoV-2, Influenza A, and Influenza B, and REVEALCOVID-19, an antibody test for COVID-19. Beyond diagnostic kits, MedMira provides the Miriad RVF toolkit, a platform that facilitates the development and market entry of rapid diagnostics. MedMira distributes its offerings through a wide network of medical distributors and strategic partners. Its customer base is broad, serving various segments of the healthcare industry, including clinical laboratories, hospitals, point-of-care clinics, government agencies, humanitarian aid groups, and public health bodies. The company was established in 1993, is headquartered in Halifax, Canada, and operates as a subsidiary of MedMira Holding AG.
Harga Saham
$0.04403621
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$30.90M
Perubahan (1 hari)
-7.69%
Perubahan (1 tahun)
-12.73%
Negara
CA
Perdagangan MedMira Inc. (MIR)

Kategori

Healthcare
Margin Operasi untuk MedMira Inc. (MIR)
Margin Operasi pada 2026 TTM: 0.00%
Menurut laporan kewangan dan harga saham terkini MedMira Inc., margin operasi semasa (TTM) ialah 0.00%. Pada akhir 2026, margin operasi syarikat ialah 0.00%.
Sejarah Margin Operasi untuk MedMira Inc. dari 2026 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
Tidak cukup data untuk tarikh yang disediakan.
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.